U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951087) titled 'Intravitreal and Intracameral DEX in NPDR' on Jan. 07.
Brief Summary: To investigate the effects of intravitreal and intracameral injection of dexamethasone during cataract phacoemulsification in patients with mild to moderate non-proliferative diabetic retinopathy
Study Start Date: Jan. 31, 2022
Study Type: INTERVENTIONAL
Condition:
Non-Proliferative Diabetic Retinopathy
Intervention:
DRUG: Dexamethasone sodium phosphate
In patients with stable DR and no significant macular edema, intravitreal anti-VEGF injections after phacoemulsification surgery can prevent the worsening of postoperative macular edema and potentially improve...